Safety Action Notice - SAN(SC)18/03

NHS Boards and local authorities may come within scope of the new in vitro diagnostic and medical device regulations. MHRA is consulting stakeholders who may be eligible to apply for exemption. To get the best range of views and allow health institutions to test and model the guidance, MHRA’s consultation will run for over 12 months and is not scheduled to close until 31st March 2019.